AVLN Avalyn Pharma Inc.

NSC
$39.25

Avalyn Pharma Inc. (AVLN) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is a loss of $0.64 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +7.7% since its last earnings release on August 12, 2026.

Avalyn Pharma Beat Consensus Estimates
Wednesday, August 12, 2026 · 8:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.64)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $37.56

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology